| 形态 | Liquid |
|---|---|
| 宿主种属 | Human |
| 克隆性 | Monoclonal |
| 抗体亚型 | IgG1-kappa |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 浓度 | 1mg/ml |
| 内毒素水平 | Please contact the lab for this information. |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 种属反应性 | Human |
| 靶标 | Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A |
| 储存缓冲液 | 0.01M PBS, pH 7.4. |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| 表达系统 | Mammalian Cells |
| 登录号 | P15692 |
| 背景信息 | Suvemcitug is a humanized IgG1κ antibody targeting VEGF derived from the African hare (Oryctolagus cuniculus). • Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy., PMID:12409337 • Vascular endothelial growth factor and its receptors., PMID:7515293 • Tumors: wounds that do not heal-redux., PMID:25568067 • Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis., PMID:12461084 • Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues., PMID:8527159 • Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin., PMID:9036922 • Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206., PMID:9529385 • Effects of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidney., PMID:9568844 • Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A/VPF-induced pathological angiogenesis., PMID:21411713 • Isolation and purification of vascular endothelial growth factor (VEGF) from ascitic fluid of ovarian cancer patients., PMID:15188027 |
| 别名 | 1610010-57-5 |
| 备注 | For research use only. Not suitable for clinical or therapeutic use. |
| 产品名称 | 点击数 |
|---|---|
| 炔诺酮单抗 | 5756 |
| 磺胺氯吡嗪单抗 | 5730 |
| 呋喃苯烯酸钠单抗 | 5584 |
| 呋喃它酮代谢物(2-NPAMOZ)单抗 | 5568 |
| 呋喃西林代谢物(2-NPSEM)单抗 | 5405 |
| 磺胺喹恶啉单抗 | 5629 |
| 苯丙酸诺龙单抗 | 5549 |
| 司帕沙星单抗 | 5411 |
| 妥布霉素单抗 | 5594 |
| 甲氧氯普胺单抗 | 5480 |
| 莫能菌素单抗 | 5584 |
| 多粘菌素B(粘菌素)单抗 | 5889 |
| 磺胺类单抗 | 5779 |
| 托灭酸(托芬那酸)单抗 | 5494 |
| 卡洛芬单抗 | 5406 |
| 喹乙醇代谢物MQCA单抗 | 5590 |
| 氟尼辛单抗 | 5534 |
| 磺胺二甲嘧啶(SM2)单抗 | 5326 |
| 诺龙(19-去甲睾酮)单抗 | 5418 |
| 阿苯达唑-2-氨基砜单抗 | 5406 |